Hydrogen Bromide → HCID 19101723, compound
Reaction equation
[CH2:1]([O:8][N:9]1[C:38](=[O:39])[CH:37]=[C:12]2[N:13]([CH:34]3[CH2:36][CH2:35]3)[C:14]3[CH:19]=[C:18]([N:20]4[CH2:25][CH2:24][N:23](C(OC(C)(C)C)=O)[CH2:22][CH2:21]4)[C:17]([F:33])=[CH:16][C:15]=3[N:11]2[C:10]1=[O:40])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.Br>C(O)(=O)C>[CH2:1]([O:8][N:9]1[C:38](=[O:39])[CH:37]=[C:12]2[N:13]([CH:34]3[CH2:35][CH2:36]3)[C:14]3[CH:19]=[C:18]([N:20]4[CH2:25][CH2:24][NH:23][CH2:22][CH2:21]4)[C:17]([F:33])=[CH:16][C:15]=3[N:11]2[C:10]1=[O:40])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
tert-Butyl 4-[2-(benzyloxy)-5-cyclopropyl-8-fluoro-1,2,3,5-tetrahydro-1,3-dioxopyrimido[1,6-a]benzimidazol-7-yl]-1-piperazinecarboxylate (580 mg, 1.05 mmol) is treated with 33 percent hydrobromic acid in glacial acetic acid (5 ml). After 18 hours at room temperature the separated crystals are filtered off, washed with glacial acetic acid and recrystallized from methanol. The crystals are then dissolved in a water/ethanol mixture (2:1, 50 ml). The pH is adjusted to 8 using 1N sodium hydroxide solution, whereby white crystals separate. The crystals are filtered off, washed with water and dried in a high vacuum. There are obtained 417 mg (88%) of 2-(benzyloxy)-5-cyclopropyl-8-fluoro-7-(1-piperazinyl)pyrimido[1,6-a]benzimidazole-1,3(2H,5H)-dione.
Workup
- filtrationAfter 18 hours at room temperature the separated crystals are filtered off
- washwashed with glacial acetic acid
- customrecrystallized from methanol
- dissolutionThe crystals are then dissolved in a water/ethanol mixture (2:1, 50 ml)
- customseparate
- filtrationThe crystals are filtered off
- washwashed with water
- customdried in a high vacuum
Sources & evidence
- ORD record
- ord-b4447a9c46e84aa1926fb730c6ecc93e
- Source dataset
- uspto-grants-1994_02
- Patent number
- US05283248
Reaction notes
Loading…